UNITED ~~STATESSECURITIES~~STATES SECURITIES AND EXCHANGE ~~COMMISSIONWashington~~COMMISSION Washington, D.C. 20549 Form 6-K

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~February~~March 2023

Commission File Number: 001-38524

Titan Medical Inc. (Exact Name of Registrant as Specified in Charter) 76 Berkeley Street

~~76 Berkeley Street~~ Toronto, Ontario M5A 2W7 ~~Canada (Address of principal executive offices)~~

~~Indicate~~Canada (Address ~~by check mark whether the registrant files or will file annual reports under cover~~ of ~~Form~~principal ~~20-F~~executive ~~or Form 40-F.Form 20-F [ X ] Form 40-F [ ]~~offices)

Indicate by check mark ifwhether the registrant isfiles ~~submitting~~or ~~the~~will ~~Form~~file ~~6-K~~annual reports inunder ~~paper~~cover asForm ~~permitted~~20-F byor ~~Regulation~~Form S40-~~T Rule 101(b)(1):~~ F.

~~Note: Regulation~~Form S20-TF ☒ ~~Rule 101(b)(1) only permits the submission in paper of a~~ Form 640-KF ~~if submitted solely to provide an attached annual report to security holders.~~☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		Titan Medical Inc.
		TITAN MEDICAL INC.
		(Registrant)
Date: February 14, 2023		/s/ Stephen Lemieux
Date:	March 6, 2023	By:	/s/ Stephen Lemieux
		Stephen Lemieux
		Name:	Stephen Lemieux
		Chief Financial Officer
		Title:	Chief Financial Officer

EXHIBIT INDEX

Exhibit Number		Description
99.1		Press Release dated February 14, 2023

99.1	Material Change Report

Filing Compare · TITAN MEDICAL INC